Francesca Romana Mauro

Pubblicazioni

Titolo	Pubblicato in	Anno
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience	BRITISH JOURNAL OF HAEMATOLOGY	2019
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia	HEMATOLOGICAL ONCOLOGY	2019
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12	CANCERS	2019
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia	BRITISH JOURNAL OF CANCER	2019
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia	LEUKEMIA	2019
TP53 CLONAL AND SUBCLONAL ARCHITECTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER IBRUTINIB TREATMENT.	HemaSphere	2019
IBRUTINIB TREATMENT DOESN’T INDUCE TP53 CLONAL EVOLUTION IN CHRONIC LYMPHOCYTIC LEUKEMIA.	Haematologica 2019; 104(s2):1	2019
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding	HEMATOLOGICAL ONCOLOGY	2018
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients	ANNALS OF ONCOLOGY	2018
Venetoclax: a chance for patients with chronic lymphocytic leukaemia previously treated with ibrutinib	THE LANCET ONCOLOGY	2018
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases	AMERICAN JOURNAL OF HEMATOLOGY	2018
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile	LEUKEMIA	2018
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.	BRITISH JOURNAL OF HAEMATOLOGY	2018
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study	HAEMATOLOGICA	2018
Gene mutations in lenalidomide-treated CLL	BLOOD	2018
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics	BRITISH JOURNAL OF HAEMATOLOGY	2018
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study	BLOOD	2018
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment.	EUROPEAN JOURNAL OF HAEMATOLOGY	2018
Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases	AMERICAN JOURNAL OF HEMATOLOGY	2018
Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemia	EXPERT REVIEW OF HEMATOLOGY	2018

Pubblicazioni

Progetti di Ricerca